1. Home
  2. TXG vs TWST Comparison

TXG vs TWST Comparison

Compare TXG & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$21.98

Market Cap

2.8B

Sector

Industrials

ML Signal

HOLD

Logo Twist Bioscience Corporation

TWST

Twist Bioscience Corporation

HOLD

Current Price

$48.76

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXG
TWST
Founded
2012
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.0B
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
TXG
TWST
Price
$21.98
$48.76
Analyst Decision
Hold
Buy
Analyst Count
14
8
Target Price
$16.82
$48.75
AVG Volume (30 Days)
2.6M
1.5M
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
76.97
63.89
EPS
N/A
N/A
Revenue
$245,893,000.00
$376,572,000.00
Revenue This Year
N/A
$18.89
Revenue Next Year
$7.32
$15.28
P/E Ratio
N/A
N/A
Revenue Growth
68.06
20.32
52 Week Low
$6.78
$23.30
52 Week High
$23.56
$57.88

Technical Indicators

Market Signals
Indicator
TXG
TWST
Relative Strength Index (RSI) 64.85 55.47
Support Level $11.62 $25.67
Resistance Level $23.56 $57.88
Average True Range (ATR) 1.29 3.01
MACD 0.20 -0.56
Stochastic Oscillator 99.89 22.97

Price Performance

Historical Comparison
TXG
TWST

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Share on Social Networks: